Narrow Results

INDIA – Bioven starts BV-NSCLC-001 Phase III trial in NSCLC.

INDIA – Initiative in Chemical Biology and Therapeutics.

PHILLIPPINES – Asia–Pacific Analysis: The slow road to green energy.

SINGAPORE – Takeda progressing well in Asia with New Drug Applications.

SINGAPORE – NTU and University of Warwick boost brainpower in global neuroscience research.

THAILAND – Thai PhD. student awarded Monsanto's Beachell–Borlaug International Scholarship for rice improvement research.

EUROPE – Open access will change the world, if scientists want it to.

UNITED STATES & CANADA – Verisante places Aura Beta Units for safety, verification testing in B.C., Alberta and Ontario clinics.

UNITED STATES & CANADA – Life Technologies sets new worldwide standard for criminal forensic testing with introduction of GlobalFilerTM Express Kit.

UNITED STATES & CANADA – How immune cells can nudge nerves to regrow.

UNITED STATES & CANADA – Improved Genomic Target Selection Using IDT Oligos.

UNITED STATES & CANADA – US team uncover non-invasive method for diagnosing epilepsy.

Bone Healing from Within

How Technology Helps in Care Coordination: Telehealth?

Soft Wearable Machines for Robot-Assisted Rehabilitation

Technology Can Help Patients Find Doctors and Share Medical Data

Seizing Opportunity in Asia-Pacific's Complex and Rapidly Changing Medical Device Market

How Logistics Technology Can Treat Tomorrow's Life Sciences & Healthcare Complications

SINGAPORE – The Only Singapore Private Hospital to Achieve Success at Asian Hospital Management Awards 2016.

UNITED STATES – Study Finds Vision Loss Due to Diabetes Is Rising Globally.

UNITED STATES – How Sleep Deprivation Harms Memory.

UNITED KINGDOM – Plasticell and CellSpring Collaborate to Validate Osteogenic Cell Therapy and 3D Cell Culture Models for High Performance Drug Screening.

JAPAN – Takeda Announces Bold, New Access to Medicines Strategy.

THAILAND – Ministry of Public Health Embarks on eHealth in Thailand with VMware Virtualization and Mobility Solutions.

AUSTRALIA – Australian-led Global Sleep Apnea Medical Device Study Shows Treatment Improves Wellbeing but Without Any Cardiovascular Benefit.

RUSSIA – R-Pharm Produces Biological Drugs in Yaroslavl with GE Healthcare's FlexFactory™ Manufacturing Platform.

AUSTRALIA & RUSSIA – Pharmaxis Announces Russian Approval for Bronchitol Largest Market Accessed to Date.

ATOZET® a New Combination Treatment Option for High-Risk Patients to Lower LDL Cholesterol, is Now Approved in Singapore.

ASEAN+ Rare Disease Network Established.

Luye Medical Joins Forces with OncoCare To Expand Its Integrated Healthcare Services Platform for Their Patients.

NUS Pharmacy Team Develops Online “Calculator” to Predict Risk of Early Hospital Readmission.

The Bare Essentials: Ensuring Affordable Access to Insulin.

AstraZeneca’s CVD-REAL Study Shows SGLT-2 Inhibitors Significantly Reduced Death and Hospitalisations for Heart Failure Versus Other Type-2 Diabetes Medicines.

This paper develops alternative models explaining why households with credit need to finance their projects (enterprises) avoid formal credit. More importantly it argues that the problem of avoidance of formal credit and ensuring credit access is not necessarily restricted to the small borrower or borrowers with inefficient projects. Delay cost and personal loan transaction cost may also cause highly productive projects or larger projects shying away from formal credit in spite of low interest rates. Some of the policy implications of the above findings are also discussed.

Food security is a complex phenomenon made up of multiple dimensions — food availability, physical access to food, economic access to food, food utilization — each of which has a stability dimension which underpins it. This review provides details on these dimensions and links them to two published indices which provide assessments of the state of food security in a country. The paper further provides analyses of the main supply and demand factors in the food security equation. Food security faces natural and anthropogenic threats such as loss of productive land and water, climate change and declining crop productivity, all of which are potentially amenable to solutions provided by science and technology. Demographic and accompanying diet changes further exacerbate the demands made on the natural resource base for food production. Finally, possible responses to the challenges confronting a secured food future are discussed from technological, policy and system level perspectives.

We are in an era of knowledge revolution where knowledge occupies the centre stage. Its continuous generation, sharing and implementation have become crucial for firms and countries. This revolution is supported by the revolution in information technologies. This present research is an attempt to find out the state of knowledge storage and access in Indian industry. To have a macro view of the situation, industry and academia experts and policy makers were consulted regarding knowledge storage and access in Indian industry. To have the micro view, five firms were selected from both the software and pharmaceutical industries, and four firms from the petroleum marketing sector, thus covering both private and public sectors. The findings were mixed. Whereas access to knowledge is good, in general there is a lack of continuous update of stored knowledge.

This paper highlights challenges of water access in towns and cities of the global South and explores potential policy responses. These challenges are not new, although, we argue that they have been underestimated by policy makers due to a focus on global data, thus, resulting in decision makers paying insufficient attention to these problems. Policies need to be based on a more accurate assessment of challenges, specifically the need for continuous and affordable water service, and the need to provide services to informal settlements. We share findings from research on 15 cities across Latin America, Asia, and Africa.

Background: Fertility physicians are gatekeepers of assisted reproductive technology (ART) and have immediate control over access to fertility care. However, little is understood about their attitudes and willingness to provide and support different procedures. Therefore, we examined fertility physicians’ perspectives on support of public funding and willingness to provide care in various scenarios.

Methods: We invited fertility physicians attending the 8th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2018) to participate in a 10-minute survey. Participants completed the survey anonymously and in private.

Results: 78 out of 105 fertility physicians from 12 countries completed the survey (response rate = 74.3%). Mean age was 44.9 years (SD = 11.1). A majority of respondents supported public funding for ART: 76.3% for intrauterine insemination and 80.5% for in vitro fertilization. For controversial procedures, a majority agreed to provide social egg freezing (88.5%) compared to sex selection (25.6%) and gene editing for nonmedical reasons (19.2%), p < 0.001 for both comparisons. Support for public funding was also significantly higher for social egg freezing (51.3%) compared to sex selection (23.1%) and gene editing for nonmedical reasons (20.5%), p < 0.001 for both comparisons. For eligibility criteria, willingness to provide treatment to single women (50.0%) was significantly higher compared to other nontraditional family structures — single men (33.3%), p < 0.001, male homosexual couples (33.3%), p = 0.002, female homosexual couples (32.1%), p = 0.001 and unmarried heterosexual couples (32.1%), p = 0.004. Consistently, support for public finding was significantly higher for single women (32.1%) compared to single men (23.1%), p = 0.013, male homosexual couples (20.5%), p = 0.020, and unmarried heterosexual couples (20.5%), p = 0.006.

Conclusions: These results show support for public funding and conservative opinions toward ART for nontraditional family structures among physicians in the Asia-Pacific region.

Data collection when working with vulnerable populations can be a challenging endeavor, but once data are collected, it can be communicated through storytelling. Storytelling provides an undoubtedly valuable resource for academics seeking for the voices of participants to be heard in academic writing. This chapter aims to provide readers with a deeper understanding of the data collection process when studying undocumented Latinx immigrants. Getting access to informants was particularly challenging since data for this ethnographic study were collected in the months preceding and following Donald Trump’s election in 2016. This population had long faced adversities; however, their difficulties were further enhanced by Trump’s discriminatory rhetoric. Telling the stories of undocumented Latinx immigrants will allow their narratives to be known within the management literature. This effort can help this particular group to get more attention in order for scholars to develop further research which might have an impact not only on research projects but also on the development of public policy.

A way of establishing user developing information management for database access through middleware is introduced. We put the data needed for share on the LAN so that users on the LAN can access the data according to the given authority to realize resource share. Yet, the system can be realized on the Internet. The shared data can be accessed through broadband or Internet telephone to extend the scope of system application. Through changing relevant configuration, the development interfaces provided by the middleware can be kept unchanged and the system developed by users can also be kept unchanged. It reduces the work of user's development. The progress and performance of entire system can be improved by letting the professional computer programmer to accomplish.

Prescription pharmaceutical spending accounts for a significant proportion of total health spending, ranging from over a third to just under a sixth in OECD and emerging countries and is the second largest component of health budgets after salaries of health care professionals. Given the peculiarities of pharmaceutical markets (multiple stakeholders, oligopolistic structure, imperfect information and agency) and the multiple — sometimes conflicting — objectives of pharmaceutical policy (macroeconomic efficiency, microeconomic efficiency, quality of care, access, and promotion of industrial policy including R&D investment), governments and health insurers intervene in pharmaceutical markets. Such intervention takes place both on the supply- and demand-side and focuses on a number of key variables, such as the prices of prescription pharmaceuticals, the barriers to entry in individual markets, the behavior of or the choices made by health care professionals (doctors and pharmacists) and the choices patients make. The policy mix in order to satisfy the above policy objectives varies quite dramatically across countries and so does the effectiveness of individual policy measures and the rigor with which they are pursued. This chapter outlines the importance of pharmaceuticals as a health care input, discusses the supply- and demand-side strategies in order to influence prices, volume and expenditure, the various modalities with which they are implemented in different settings, and presents evidence on the impact of such intervention by drawing on the international literature.

This paper assesses the impact of regulatory quality, along with a number of political, economic, and social mechanisms, on disparities in access to clean water and adequate sanitation. We offer a series of vignettes using cross-national data from 2002 and 2004 to assess the effects of key institutional variables on the improvement of access to safe water and sanitation. The evidence is mixed for the two key variables of a country's commitment to "quality regulation" and the country's long-term development path as expanding or contracting access to water and sanitation.